Lucid Diagnostics (LUCD) Interest & Investment Income (2022 - 2026)
Lucid Diagnostics (LUCD) posted Interest & Investment Income of $70000.0 for Q1 2026, down 36.36% on a QoQ basis from $110000.0 in Q4 2025, and up 6.06% year-over-year from $66000.0 in Q1 2025.
Lucid Diagnostics (LUCD) Interest & Investment Income (2022 - 2026) Analysis & Trends
Lucid Diagnostics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $70000.0 for Q1 2026.
- Quarterly Interest & Investment Income rose 6.06% year-over-year to $70000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $391000.0 (up 22.19% YoY) and the FY2025 annual result came in at $386000.0, up 19.88% from the prior year.
- Interest & Investment Income was $70000.0 for Q1 2026 at Lucid Diagnostics, down from $110000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $136000.0 in Q2 2023 and bottomed at $1000.0 in Q1 2022.
- A 5-year average of $75941.2 and a median of $78000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 7700.0% — and 2024, when it tumbled 30.17%.
- Lucid Diagnostics' Interest & Investment Income stood at $55000.0 in 2022, then surged by 70.91% to $94000.0 in 2023, then retreated by 29.79% to $66000.0 in 2024, then surged by 66.67% to $110000.0 in 2025, then tumbled by 36.36% to $70000.0 in 2026.
- Business Quant data shows LUCD's Interest & Investment Income at $70000.0 in Q1 2026, $110000.0 in Q4 2025, and $101000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Lucid Diagnostics | 126.55 Mn | 98.67 Mn | -325,000.00 | 70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Jun 30, 2025 | 110,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | 94,000.00 |
| Sep 30, 2023 | 116,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Mar 31, 2023 | 78,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 1,000.00 |